Equities
Health CarePharmaceuticals and Biotechnology
  • Price (EUR)46.85
  • Today's Change0.35 / 0.75%
  • Shares traded6.07k
  • 1 Year change-23.94%
  • Beta0.6291
Data delayed at least 15 minutes, as of Nov 22 2024 16:36 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of EUR
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments279.8225
Total Receivables, Net281512
Total Inventory0.470.570.21
Prepaid expenses114.640.62
Other current assets, total------
Total current assets673138
Property, plant & equipment, net12128.43
Goodwill, net45450
Intangibles, net5084880.73
Long term investments25827924
Note receivable - long term------
Other long term assets------
Total assets89085471
LIABILITIES
Accounts payable16117.61
Accrued expenses2.681.291.19
Notes payable/short-term debt000
Current portion long-term debt/capital leases22220.88
Other current liabilities, total29160.74
Total current liabilities695110
Total long term debt7.87284.41
Total debt30495.28
Deferred income tax123120--
Minority interest------
Other liabilities, total188299--
Total liabilities38849715
SHAREHOLDERS EQUITY
Common stock161511
Additional paid-in capital------
Retained earnings (accumulated deficit)48734145
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity50335756
Total liabilities & shareholders' equity89085471
Total common shares outstanding161511
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.